BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 31131640)

  • 21. Development and validation of the comprehensive assessment scale for chemotherapy-induced peripheral neuropathy in survivors of cancer.
    Kanda K; Fujimoto K; Mochizuki R; Ishida K; Lee B
    BMC Cancer; 2019 Sep; 19(1):904. PubMed ID: 31506070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the impact of chemotherapy-induced peripheral neuropathy symptoms (CIPN-sx) on perceived ability to work in breast cancer survivors during the first year post-treatment.
    Zanville NR; Nudelman KN; Smith DJ; Von Ah D; McDonald BC; Champion VL; Saykin AJ
    Support Care Cancer; 2016 Nov; 24(11):4779-89. PubMed ID: 27470258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
    Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
    Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Age-related differences in patient-reported and objective measures of chemotherapy-induced peripheral neuropathy among cancer survivors.
    Wong ML; Cooper BA; Paul SM; Abrams G; Topp K; Kober KM; Chesney MA; Mazor M; Schumacher MA; Conley YP; Levine JD; Miaskowski C
    Support Care Cancer; 2019 Oct; 27(10):3905-3912. PubMed ID: 30770977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Yoga for Chemotherapy-Induced Peripheral Neuropathy and Fall Risk: A Randomized Controlled Trial.
    Bao T; Zhi I; Baser R; Hooper M; Chen C; Piulson L; Li QS; Galantino ML; Blinder V; Robson M; Seidman A; Panageas KS; Mao JJ
    JNCI Cancer Spectr; 2020 Dec; 4(6):pkaa048. PubMed ID: 33225208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
    Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
    J Patient Rep Outcomes; 2023 Nov; 7(1):113. PubMed ID: 37947987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise-based rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy.
    McCrary JM; Goldstein D; Sandler CX; Barry BK; Marthick M; Timmins HC; Li T; Horvath L; Grimison P; Park SB
    Support Care Cancer; 2019 Oct; 27(10):3849-3857. PubMed ID: 30756229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of yoga on functional outcomes in breast cancer survivors with aromatase inhibitor-associated arthralgias.
    Galantino ML; Desai K; Greene L; Demichele A; Stricker CT; Mao JJ
    Integr Cancer Ther; 2012 Dec; 11(4):313-20. PubMed ID: 21733988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Exercise on Chemotherapy-Induced Peripheral Neuropathy Among Patients Treated for Ovarian Cancer: A Secondary Analysis of a Randomized Clinical Trial.
    Cao A; Cartmel B; Li FY; Gottlieb LT; Harrigan M; Ligibel JA; Gogoi R; Schwartz PE; Esserman DA; Irwin ML; Ferrucci LM
    JAMA Netw Open; 2023 Aug; 6(8):e2326463. PubMed ID: 37526937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patient-Reported Outcome Measures in Chemotherapy-Induced Peripheral Neurotoxicity: Defining Minimal and Clinically Important Changes.
    Li T; Timmins HC; Trinh T; Mizrahi D; Harrison M; Horvath LG; Grimison P; Friedlander M; Kiernan MC; King MT; Rutherford C; Goldstein D; Park SB
    J Natl Compr Canc Netw; 2023 Feb; 21(2):125-132.e3. PubMed ID: 36791763
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy.
    Winters-Stone KM; Horak F; Jacobs PG; Trubowitz P; Dieckmann NF; Stoyles S; Faithfull S
    J Clin Oncol; 2017 Aug; 35(23):2604-2612. PubMed ID: 28586243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Experience of Chemotherapy-Induced Peripheral Neuropathy Among Childhood Cancer Survivors.
    Mohrmann C
    J Pediatr Oncol Nurs; 2019; 36(6):413-423. PubMed ID: 31057036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sensorimotor training and whole-body vibration training have the potential to reduce motor and sensory symptoms of chemotherapy-induced peripheral neuropathy-a randomized controlled pilot trial.
    Streckmann F; Lehmann HC; Balke M; Schenk A; Oberste M; Heller A; Schürhörster A; Elter T; Bloch W; Baumann FT
    Support Care Cancer; 2019 Jul; 27(7):2471-2478. PubMed ID: 30382392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Influence of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life of Gynecologic Cancer Survivors.
    Matsuoka H; Nakamura K; Matsubara Y; Ida N; Saijo M; Ogawa C; Masuyama H
    Int J Gynecol Cancer; 2018 Sep; 28(7):1394-1402. PubMed ID: 30095701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial.
    Schwenk M; Grewal GS; Holloway D; Muchna A; Garland L; Najafi B
    Gerontology; 2016; 62(5):553-63. PubMed ID: 26678611
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Chemotherapy-Induced Peripheral Neuropathy on Quality of Life in Patients with Advanced Lung Cancer Receiving Platinum-Based Chemotherapy.
    Hung HW; Liu CY; Chen HF; Chang CC; Chen SC
    Int J Environ Res Public Health; 2021 May; 18(11):. PubMed ID: 34073174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy.
    Tofthagen CS; Cheville AL; Loprinzi CL
    Curr Oncol Rep; 2020 Apr; 22(5):50. PubMed ID: 32323068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychometric testing of the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy.
    Cheng HL; Lopez V; Lam SC; Leung AKT; Li YC; Wong KH; Au JSK; Sundar R; Chan A; De Ng TR; Suen LKP; Chan CW; Yorke J; Molassiotis A
    Health Qual Life Outcomes; 2020 Jul; 18(1):246. PubMed ID: 32703223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Yoga on Cancer-Related Fatigue and on Mediational Relationships Between Changes in Sleep and Cancer-Related Fatigue: A Nationwide, Multicenter Randomized Controlled Trial of Yoga in Cancer Survivors.
    Lin PJ; Kleckner IR; Loh KP; Inglis JE; Peppone LJ; Janelsins MC; Kamen CS; Heckler CE; Culakova E; Pigeon WR; Reddy PS; Messino MJ; Gaur R; Mustian KM
    Integr Cancer Ther; 2019; 18():1534735419855134. PubMed ID: 31165647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the effects of sensorimotor exercise on physical and psychological parameters in breast cancer patients undergoing neurotoxic chemotherapy.
    Vollmers PL; Mundhenke C; Maass N; Bauerschlag D; Kratzenstein S; Röcken C; Schmidt T
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1785-1792. PubMed ID: 29943097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.